Annapolis Junction, MD, Oct. 12, 2017 -- Colfax Corporation (“Colfax”) (NYSE: CFX), a leading diversified industrial technology company, today announced that it will issue a press release providing financial results for the third quarter of 2017 on the morning of Monday, November 6, 2017. The Company will hold a conference call to discuss these results beginning at 8:00 a.m. Eastern on that day, which will be open to the public through 877-303-7908 (U.S. callers) and +1-678-373-0875 (international callers) and referencing the conference ID number 99101105 or through webcast via Colfax’s website www.colfaxcorp.com under the “Investors” section.
Colfax’s financial results press release and supplemental financial information referenced on the call, if any, for the third quarter of 2017 will be available under the “Investors” section of Colfax’s website prior to the conference call. A link to a replay of the call will also be available on the Colfax website later that day.
ABOUT COLFAX CORPORATION — Colfax Corporation is a leading diversified industrial technology company that provides gas- and fluid-handling and fabrication technology products and services to customers around the world under the Howden, Colfax Fluid Handling, and ESAB brands. Colfax believes that its brands are among the most highly recognized in each of the markets that it serves. Colfax is traded on the NYSE under the ticker “CFX.” Additional information about Colfax is available at www.colfaxcorp.com.
CAUTIONARY NOTE CONCERNING FORWARD LOOKING STATEMENTS:
This press release may contain forward-looking statements, including forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements concerning Colfax's plans, objectives, expectations and intentions and other statements that are not historical or current fact. Forward-looking statements are based on Colfax's current expectations and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward-looking statements. Factors that could cause Colfax's results to differ materially from current expectations include, but are not limited to factors detailed in Colfax's reports filed with the U.S. Securities and Exchange Commission including its 2016 Annual Report on Form 10-K under the caption "Risk Factors." In addition, these statements are based on a number of assumptions that are subject to change. This press release speaks only as of this date hereof. Colfax disclaims any duty to update the information herein.
The term "Colfax" in reference to the activities described in this press release may mean one or more of Colfax's global operating subsidiaries and/or their internal business divisions and does not necessarily indicate activities engaged in by Colfax Corporation.
Investor Contact: Terry Ross, VP of Investor Relations Colfax Corporation (301) 323-9054 [email protected]


Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Boeing Secures Multi-Billion Dollar Defense Contracts for F-15IA Jets and E-4B Aircraft Support
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
China’s Iron Ore Buyer Pressures Mining Giants as New Supply Shifts Market Power
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Trump Administration Probes Corporate DEI Programs, Raising Questions for Google Stock
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
China’s LandSpace Takes Aim at SpaceX With Reusable Rocket Ambitions
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Leapmotor Targets 4 Million Annual EV Sales as Global Expansion Accelerates
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy 



